Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular diseaseNobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Cancer|October 15, 2013
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral responseYasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitisKento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
Cancer Reports (Hoboken, N.J.)|March 18, 2022
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapyShuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology|June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular diseaseNobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Cancer|October 15, 2013
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral responseYasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitisKento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
Cancer Reports (Hoboken, N.J.)|March 18, 2022
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapyShuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Pageof 13